These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 12186841)

  • 1. Surface cathepsin B protects cytotoxic lymphocytes from self-destruction after degranulation.
    Balaji KN; Schaschke N; Machleidt W; Catalfamo M; Henkart PA
    J Exp Med; 2002 Aug; 196(4):493-503. PubMed ID: 12186841
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of primary human cytotoxic T-cell and natural killer cell responses reveal similar molecular requirements for lytic granule exocytosis but differences in cytokine production.
    Chiang SC; Theorell J; Entesarian M; Meeths M; Mastafa M; Al-Herz W; Frisk P; Gilmour KC; Ifversen M; Langenskiöld C; Machaczka M; Naqvi A; Payne J; Perez-Martinez A; Sabel M; Unal E; Unal S; Winiarski J; Nordenskjöld M; Ljunggren HG; Henter JI; Bryceson YT
    Blood; 2013 Feb; 121(8):1345-56. PubMed ID: 23287865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Caspase dependence of target cell damage induced by cytotoxic lymphocytes.
    Sarin A; Haddad EK; Henkart PA
    J Immunol; 1998 Sep; 161(6):2810-6. PubMed ID: 9743340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human and mouse perforin are processed in part through cleavage by the lysosomal cysteine proteinase cathepsin L.
    Konjar S; Sutton VR; Hoves S; Repnik U; Yagita H; Reinheckel T; Peters C; Turk V; Turk B; Trapani JA; Kopitar-Jerala N
    Immunology; 2010 Oct; 131(2):257-67. PubMed ID: 20497254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytotoxic T lymphocytes from cathepsin B-deficient mice survive normally in vitro and in vivo after encountering and killing target cells.
    Baran K; Ciccone A; Peters C; Yagita H; Bird PI; Villadangos JA; Trapani JA
    J Biol Chem; 2006 Oct; 281(41):30485-91. PubMed ID: 16914553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Residual active granzyme B in cathepsin C-null lymphocytes is sufficient for perforin-dependent target cell apoptosis.
    Sutton VR; Waterhouse NJ; Browne KA; Sedelies K; Ciccone A; Anthony D; Koskinen A; Mullbacher A; Trapani JA
    J Cell Biol; 2007 Feb; 176(4):425-33. PubMed ID: 17283185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell death mediated by alloreactive cytotoxic T cells via the granule exocytosis or the Fas pathway is independent of p34cdc2 kinase: Fas dependent killing of cells arrested in the cell cycle.
    Waring P; Müllbacher A
    Immunol Cell Biol; 2001 Jun; 79(3):264-73. PubMed ID: 11380680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An anergic cytotoxic T lymphocyte clone exhibits granule exocytosis-mediated cytotoxicity.
    Kuwano K; Akashi A; Arai S
    Cell Immunol; 1998 May; 185(2):114-22. PubMed ID: 9636689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The exocytosis of lytic granules is impaired in Vti1b- or Vamp8-deficient CTL leading to a reduced cytotoxic activity following antigen-specific activation.
    Dressel R; Elsner L; Novota P; Kanwar N; Fischer von Mollard G
    J Immunol; 2010 Jul; 185(2):1005-14. PubMed ID: 20543108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of CPP32-like proteases prevents granzyme B- and Fas-, but not granzyme A-based cytotoxicity exerted by CTL clones.
    Anel A; Gamen S; Alava MA; Schmitt-Verhulst AM; Piñeiro A; Naval J
    J Immunol; 1997 Mar; 158(5):1999-2006. PubMed ID: 9036942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impaired cytolytic activity in calreticulin-deficient CTLs.
    Sipione S; Ewen C; Shostak I; Michalak M; Bleackley RC
    J Immunol; 2005 Mar; 174(6):3212-9. PubMed ID: 15749851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The requirements for triggering of lysis by cytolytic T lymphocyte clones. II. Cyclosporin A inhibits TCR-mediated exocytosis by only selectively inhibits TCR-mediated lytic activity by cloned CTL.
    Lancki DW; Kaper BP; Fitch FW
    J Immunol; 1989 Jan; 142(2):416-24. PubMed ID: 2492047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PI3Kδ is essential for tumor clearance mediated by cytotoxic T lymphocytes.
    Putz EM; Prchal-Murphy M; Simma OA; Forster F; Koenig X; Stockinger H; Piekorz RP; Freissmuth M; Müller M; Sexl V; Zebedin-Brandl E
    PLoS One; 2012; 7(7):e40852. PubMed ID: 22808277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A selective inhibitor of dipeptidyl peptidase I impairs generation of CD8+ T cell cytotoxic effector function.
    Thiele DL; McGuire MJ; Lipsky PE
    J Immunol; 1997 Jun; 158(11):5200-10. PubMed ID: 9164937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dipeptidyl peptidase I is enriched in granules of in vitro- and in vivo-activated cytotoxic T lymphocytes.
    Brown GR; McGuire MJ; Thiele DL
    J Immunol; 1993 Jun; 150(11):4733-42. PubMed ID: 8496587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IL-1 beta convertase (ICE) does not play a requisite role in apoptosis induced in T lymphoblasts by Fas-dependent or Fas-independent CTL effector mechanisms.
    Smith DJ; McGuire MJ; Tocci MJ; Thiele DL
    J Immunol; 1997 Jan; 158(1):163-70. PubMed ID: 8977187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Concanamycin A, a powerful tool for characterization and estimation of contribution of perforin- and Fas-based lytic pathways in cell-mediated cytotoxicity.
    Kataoka T; Shinohara N; Takayama H; Takaku K; Kondo S; Yonehara S; Nagai K
    J Immunol; 1996 May; 156(10):3678-86. PubMed ID: 8621902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The death receptor pathway is not involved in alloreactive T-cell induced mitochondrial membrane permeability.
    Grüllich C; McGoldrick S; Zeiser R; Finke J
    Leuk Lymphoma; 2005 Aug; 46(8):1207-16. PubMed ID: 16085564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apoptosis-inducing factor of a cytotoxic T cell line: involvement of a secretory phospholipase A2.
    Costa-Junior HM; Hamaty FC; da Silva Farias R; Einicker-Lamas M; da Silva MH; Persechini PM
    Cell Tissue Res; 2006 May; 324(2):255-66. PubMed ID: 16609916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The design of peptidyldiazomethane inhibitors to distinguish between the cysteine proteinases calpain II, cathepsin L and cathepsin B.
    Crawford C; Mason RW; Wikstrom P; Shaw E
    Biochem J; 1988 Aug; 253(3):751-8. PubMed ID: 2845932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.